Skip to main content
Article thumbnail
Location of Repository

Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress

By Alexander Kurz, Naila Rabbani, Michael Walter, Michael Bonin, Paul J. Thornalley, Georg Auburger and Suzana Gispert


The presynaptic protein alpha-synuclein has received much attention because its gain-of-function is associated with Parkinson’s disease. However, its physiological function is still poorly understood. We studied brain regions of knock-out mice at different ages with regard to consistent upregulations of the transcriptome and focused on glyoxalase I (GLO1). The microarray data were confirmed in qPCR, immunoblot, enzyme activity, and behavior analyses. GLO1 induction is a known protective cellular response to glucose stress, representing efforts to decrease toxic levels of methylglyoxal (MG), glyoxal and advanced glycation endproducts (AGEs). Mass spectrometry quantification demonstrated a ubiquitous increase in MG and fructosyl-lysine as consequences of glucose toxicity, and consistent enhancement of certain AGEs. Thus, GLO1 induction in KO brain seems insufficient to prevent AGE formation. In conclusion, the data demonstrate GLO1 expression and glycation damage to be induced by alphasynuclein ablation. We propose that wild-type alpha-synuclein modulates brain glucose metabolism

Topics: QP
Publisher: Springer
Year: 2011
OAI identifier:

Suggested articles


  1. (2003). Alpha-synuclein aggregation and neurodegenerative diseases.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.